Pre-Open Movers 03/12: (CEMI) (INO) (APT) Higher; (ZAGG) (NCLH) (CCL) Lower (more...)

March 12, 2020 9:32 AM EDT
Get Alerts CEMI Hot Sheet
Price: $3.25 +0.93%

Overall Analyst Rating:
    NEUTRAL (Up Up)

Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Pre-Open Stock Movers

Chembio Diagnostics, Inc. (Nasdaq: CEMI) 35.8% HIGHER; entered into a worldwide strategic partnership with LumiraDx Limited to develop point-of-care diagnostic tests for the detection of the COVID-19 virus and IgM and IgG antibodies on both the LumiraDx and Chembio DPP platforms.

ZAGG Inc (Nasdaq: ZAGG) 30.6% LOWER; announced that its Board of Directors (the Board) suspended its review of strategic alternatives, which was first publicly announced on August 6, 2019. Despite a thorough and rigorous process conducted by the Board with BofA Securities assistance, during which time the Company reached out to over 60 strategic and financial parties, the Company was unable to finalize a definitive offer at a price that was not significantly below the current trading levels. The Board determined that stockholder value would be better enhanced on a standalone basis than by pursuing a transaction on the terms and pricing proposed.

INOVIO Pharmaceuticals, Inc. (NASDAQ: INO) 31% HIGHER; announced today that it has received a new $5 million grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale up of CELLECTRA® 3PSP proprietary smart device for the intradermal delivery of INO-4800, a DNA vaccine for COVID-19. INO-4800 is in preclinical studies and is planned to advance into Phase 1 clinical trials in the U.S. in April with up to $9 million funding from CEPI. INOVIO plans to accelerate the testing and scale up of the CELLECTRA 3PSP devices to support large scale manufacturing of INO-4800 doses by the end of 2020.

Alpha Pro Tech, Ltd. (NYSE: APT) 30.4% HIGHER; announced an update to the status of orders booked for APTs personal protective equipment products in connection with the coronavirus (Covid-19) pandemic.

Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) 26.1% LOWER; Carnival's Princess Cruises announced that it will voluntarily pause global operations of its 18 cruise ships for two months (60 days)

Royal Caribbean Cruises Ltd. (NYSE: RCL) 23.8% LOWER; Carnival's Princess Cruises announced that it will voluntarily pause global operations of its 18 cruise ships for two months (60 days)

Carnival Corporation & Plc (NYSE: CCL) 20.3% LOWER; In proactive response to the unpredictable circumstances evolving from the global spread of COVID-19 and in an abundance of caution, Princess Cruises announced that it will voluntarily pause global operations of its 18 cruise ships for two months (60 days), impacting voyages departing March 12 to May 10.

Compugen Ltd. (Nasdaq: CGEN) 19.4% LOWER; commenced an underwritten public offering, subject to market and other conditions, to issue and sell its ordinary shares. In connection with the offering, Compugen expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the ordinary shares offered in the public offering. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Aytu BioScience (NASDAQ: AYTU) 8.9% HIGHER; coronavirus play bounces after sell-off 34% today on an offering

Novavax, Inc. (NASDAQ: NVAX) 3.8% HIGHER; posts Q4 results, coronavirus play

PDL BioPharma (NASDAQ: PDLI) 3.3% LOWER; reported Q4 EPS of ($0.48), $0.53 worse than the analyst estimate of $0.05.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Bill & Melinda Gates Foundation Trust, Pre-Open Losers, Pre-Open Winners, Pre Market Movers